We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Mouse Model for Retinoblastoma Research

By Biotechdaily staff writers
Posted on 06 Apr 2004
Cancer researchers working with mice have learned that the tumor suppressor Rb protein, which when lacking can trigger retinoblastoma in young children, limits the proliferation of immature retinal cells in developing embryos and prompts specific cells to mature into light-sensitive retinal rods.

The role of Rb in the developing mouse retina had not been studied previously, as Rb-deficient embryos die before the retinas are fully formed. In the current work, investigators at St. Jude Children's Research Hospital (Memphis, TN, USA) devised several new approaches for studying Rb. These techniques include methods for knocking out Rb expression in cultured mouse retinal cells, as well as methods for knocking out Rb in single retinal progenitor cells so the effect of this mutation could be studied in both embryos and newborn mice.

A viral vector was used to insert the gene for E1A-a protein that inactivates Rb in newborn mice, whose retinas continue to develop after birth. The retinas in these newborn mice grew abnormally large and failed to develop rods. The investigators reported in the February 29, 2004, online edition of Nature Genetics that Rb was required for both proper regulation of retinal cell proliferation and for initiation of rod formation.

"Our work has also included efforts to develop a mouse model that has the same genetic mutations as those found in humans with retinoblastoma yet permits the mouse to develop and be born,” explained senior author Dr. Michael A. Dyer, assistant professor of neurobiology at St. Jude Children's Research Hospital. "This will further enhance our understanding of this devastating cancer and allow us to test new treatments that will spare children with this cancer from losing one or both eyes.”




Related Links:
St. Jude Children's Research Hospital

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Human Estradiol Assay
Human Estradiol CLIA Kit

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
06 Apr 2004  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
06 Apr 2004  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
06 Apr 2004  |   BioResearch